Mercer Global Advisors
OLMA icon

Mercer Global Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Mercer Global Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2K Buy
+3,295
New +$44.1K ﹤0.01% 4419

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JTL
Jupiter Topco LLC New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Mercer Global Advisors's OLMA Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 3,295 shares worth $41.2K. The stake represents ﹤0.01% of the portfolio and ranks #4419 among its holdings.

167 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Mercer Global Advisors held 3,295 shares of Olema Pharmaceuticals worth $41.2K as of Q2 2026.
  • Olema Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4419 holding.
  • 167 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.